Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Covington
AstraZeneca
Baxter
Novartis
QuintilesIMS
Farmers Insurance
Accenture
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,246,418

« Back to Dashboard

Summary for Patent: 5,246,418
Title: Iontophresis system having features for reducing skin irritation
Abstract:An iontophoresis drug delivery system includes a device which is attachable to the skin of an animal and having a drug reservoir, an electrolyte reservoir, and electrodes electrically communicating with the reservoirs and with the skin of the animal. An electronic circuit for controlling the rate or amount of current or voltage applied to the electrodes of the device includes a constant voltage and current generator, and a switching circuit for switching between applying either a constant current to the electrodes or a constant voltage. Current and voltage sensors are attached to the electrodes and provide feedback signals which are compared with predetermined threshold signals to control through feedback the amount of constant voltage and constant current applied to the electrodes.
Inventor(s): Haynes; John L. (Chapel Hill, NC), Sage, Jr.; Burton H. (Raleigh, NC)
Assignee: Becton Dickinson and Company (Franklin Lakes, NJ)
Application Number:07/808,754
Patent Claim Types:
see list of patent claims
Delivery; Compound; Use; Device;

Drugs Protected by US Patent 5,246,418

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,246,418

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3019992 ➤ Subscribe
Australia 655859 ➤ Subscribe
Canada 2084734 ➤ Subscribe
Germany 69225387 ➤ Subscribe
European Patent Office 0547482 ➤ Subscribe
Japan H05245214 ➤ Subscribe
Japan H0761365 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Cerilliant
Federal Trade Commission
UBS
Farmers Insurance
Dow
Merck
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot